Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial

Publication | Open Access

DOI Full Paper Access

101

Citations

References

2023

Year

Karim Fizazi, Ken Herrmann, Bernd J. Krause, Kambiz Rahbar, Kim N., Michael J. Morris, Oliver Sartor, Scott T. Tagawa, A. Tuba Kendi, Nicholas J. Vogelzang,

The Lancet Oncology

UrologyHealth-related QualityPain MedicinePain OutcomesMedicineCancer ManagementClinical TrialsCancer PainOutcomes ResearchPatient-reported OutcomePain ManagementProstatic DiseaseOncologyRadiation OncologyHealth Sciences